SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-012844
Filing Date
2020-08-18
Accepted
2020-08-18 20:14:30
Documents
1
Period of Report
2020-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159779605540870.html 4  
1 FORM 4 wf-form4_159779605540870.xml 4 6234
  Complete submission text file 0001628280-20-012844.txt   7767
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O X4 PHARMACEUTICALS, INC. 955 MASSACHUSETTS AVENUE, 4TH FLOOR CAMBRIGE MA 02139
Business Address
Skerlj Renato (Reporting) CIK: 0001814632 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 201115050